INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

PCRXPacira BioSciences, Inc.

CIK 0001396814

EDGAR filingsOpen in network
Disclosed transactions12
Buys / sells0 / 4
Max Insider Score12
Connections3with evidence

PCRX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
RL
Riker LaurenSenior Vice President, Finance
PCRXPacira BioSciences, Inc.
Option exercise · 10b5-1 plan
M—
6,000 sh
Oct 8, 2026Oct 9, 2026
traded Oct 8, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Riker LaurenSenior Vice President, Finance · Oct 9, 2026
  • ← Insider ofevidence
    Cross ShawnChief Financial Officer · Apr 22, 2026
6
RL
Riker LaurenSenior Vice President, Finance
PCRXPacira BioSciences, Inc.
Option exercise · 10b5-1 plan
M
$194K
6,000 sh
Oct 8, 2026
Oct 9, 2026
traded Oct 8, 2026
+1d
SEC FORM 4

Evidence

12
RL
Riker LaurenSenior Vice President, Finance
PCRXPacira BioSciences, Inc.
Open-market sale · 10b5-1 plan
SELL$218K
6,000 sh
Oct 8, 2026Oct 9, 2026
traded Oct 8, 2026
+1dSEC FORM 4

Evidence

0
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Option exercise · 10b5-1 plan
M$47K
2,845 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC FORM 4

Evidence

4
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Open-market sale · 10b5-1 plan
SELL$71K
2,845 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC FORM 4

Evidence

0
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Option exercise · 10b5-1 plan
M$25K
1,500 sh
Apr 22, 2026Apr 22, 2026
traded Apr 22, 2026
+0dSEC FORM 4

Evidence

1
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
1,500 sh
Apr 22, 2026Apr 22, 2026
traded Apr 22, 2026
+0dSEC FORM 4

Evidence

0
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Option exercise · 10b5-1 plan
M—
7,714 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

0
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Option exercise · 10b5-1 plan
M—
2,845 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC FORM 4

Evidence

0
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Option exercise · 10b5-1 plan
M—
1,500 sh
Apr 22, 2026Apr 22, 2026
traded Apr 22, 2026
+0dSEC FORM 4

Evidence

6
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Option exercise · 10b5-1 plan
M$127K
7,714 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

12
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
7,714 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence